Obesity Hypoventilation Syndrome Clinical Trial
Official title:
Effectiveness of Noninvasive Ventilation Adjusted Automatically in the Obesity Hypoventilation Syndrome
Primary Objectives: To evaluate the effectiveness in the obesity hypoventilation syndrome (OHS) treatment with non-invasive ventilation (NIV) set manually by polysomnography compared to the same treatment with a respirator with automatic NIV adjustment, analyzing as primary variable PaCO2 and as operational variables dropout rate for medical reasons and mortality. Secondary objectives: cost-effectiveness, clinical and functional improvement in wakefulness and during sleep, quality of life, blood pressure monitoring for 24 hours, incidence and evolution of cardiovascular events and use of health resources. Other objectives: 1) effectiveness of treatments in the following subgroups of patients: gender, age, socioeconomic status, severity of sleep apnea, VNI compliance, quality of life and comorbidities; 2) To evaluate the profile of patients with poor adherence to NIV based on clinical severity, gender, age and socioeconomic status in the whole sample and in both intervention groups.
Method: Prospective, blind researchers, randomized, controlled non-inferiority and cost-effectiveness relationship, with two parallel open groups. 200 OHS patients will be divided into two groups by simple randomization 1:1 and followed for one year. The premise of non-inferiority is -2 at the lower limit of the confidence interval 95% for the change in PCO2 between the arms being assessed by analysis of covariance, adjusted for 2-sided, age, sex, body mass index in intention-to-treat and per-protocol analysis. The cost-effectiveness will be performed by Bayesian techniques with sensitivity analysis. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01903135 -
Prevalence of Obesity Hypoventilation Syndrome
|
N/A | |
Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
Withdrawn |
NCT03861468 -
Medico-economics and QoL of Obese Patients Followed by Medical Analysis Laboratories (BIOSAOS )
|
N/A | |
Completed |
NCT01368614 -
AVAPS-AE Efficacy Study
|
N/A | |
Terminated |
NCT01964339 -
Obesity Hypoventilation Syndrome Prevalence Study
|
||
Completed |
NCT04108819 -
Ketogenic Diet for Obesity Hypoventilation Syndrome
|
N/A | |
Completed |
NCT02934581 -
Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units
|
||
Terminated |
NCT03353064 -
Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure
|
N/A | |
Completed |
NCT03085537 -
Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Digital Diagnosis Platform
|
||
Recruiting |
NCT02980770 -
Postoperative Complications in Patients With Obesity Hypoventilation Syndrome
|
N/A | |
Completed |
NCT01499485 -
Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.
|
Phase 3 | |
Completed |
NCT01483716 -
A Trial of Rehabilitation in Obesity Hypoventilation Syndrome (OHS)
|
N/A | |
Completed |
NCT03506906 -
The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation
|
N/A | |
Terminated |
NCT02317042 -
Juno Perth Clinical Trial
|
N/A | |
Withdrawn |
NCT01104610 -
Target Volume Mode Controlled Ventilator in Obesity Hypoventilation Syndrome
|
N/A | |
Completed |
NCT01405976 -
Alternative of Treatment in Obesity Hypoventilation Syndrome
|
N/A | |
Recruiting |
NCT03854058 -
Respiratory Muscle Strength in Patients With Obesity Hypoventilation Syndrome (OHS) or With a Precursor of the Disease
|
||
Not yet recruiting |
NCT05190458 -
Evaluation of High Velocity Nasal Insufflation in Management of Respiratory Failure in Patients With Overlap Syndrome
|
N/A | |
Recruiting |
NCT04100616 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity
|
||
Completed |
NCT02342899 -
Cost Effectiveness of Outpatient Set-up of Automated NIV in Obese Patients With Chronic Respiratory Failure
|
Phase 3 |